Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome (Q39742324)

14 September 2017

title

Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome (English)

1 reference

14 September 2017

1 reference

8

Carsten Bokemeyer

1 reference

14 September 2017

Matthias Choschzick

1

1 reference

14 September 2017

Paula Lassen

2

1 reference

14 September 2017

Annette Lebeau

3

1 reference

14 September 2017

Andreas Holger Marx

4

1 reference

14 September 2017

Luigi Terracciano

5

1 reference

14 September 2017

Uwe Heilenkötter

6

1 reference

14 September 2017

Fritz Jaenicke

7

1 reference

14 September 2017

Jakob Izbicki

9

1 reference

14 September 2017

Guido Sauter

10

1 reference

14 September 2017

Ronald Simon

11

1 reference

14 September 2017

publication date

5 February 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

23

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

603-610

1 reference

Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Specificity, selection and significance of gene amplifications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

MYC in breast tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

c-myc amplifications in primary breast carcinomas and their local recurrences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

MYC amplification in breast cancer: a chromogenic in situ hybridisation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Novel patterns of genome rearrangement and their association with survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

The amplified WWP1 gene is a potential molecular target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Reactive oxygen species (ROS) in multistage carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Mitochondrial reactive oxygen species trigger hypoxia-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Hypoxia, HIF1 and glucose metabolism in the solid tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

TCEB1 promotes invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Gene amplification in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

TMEM70 protein — A novel ancillary factor of mammalian ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

Molecular cytogenetics of primary breast cancer by CGH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

The accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.5

7 January 2021

Identifiers

DOI

10.1038/MODPATHOL.2010.5

1 reference

14 September 2017

1 reference